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ABSTRACT:   Introduction: Upon hearing that the “little” patient has trouble with hearing, we are mostly interested in the level of his hearing 
threshold. When the child is in the first year of life, results can only be achieved by means of ABR test. Subsequent control 
tests, especially in children from the hearing loss risk groups selected in this study, show that the obtained outcomes are 
subject to fluctuations. Their fluctuating nature is manifested by the instability of wave V threshold in subsequent diagnostic 
periods. Such variability often delays the implementation of the appropriate proceeding. Knowledge of the dissimilarity of 
behavior of the wave V threshold occurring in individual groups at risk of hearing loss allows for the correct interpretation of 
the obtained results, and thus, effective therapeutic measures. 
  Aim: The aim of the paper is to analyze the stability of wave V threshold during the first year of life in children from selected 
risk groups for congenital hearing disorders.  
  Material and methods: From the patient population of 2,114 individuals examined in 2015–2016 at a reference center 
participating in the Universal Neonatal Hearing Screening Program in 2015–2016, the results of 250 children were subjected 
to retrospective analysis. Furthermore, 4 groups of little patients were formed (children with Down syndrome; children with 
other diseases or damage to the nervous system; children with cleft palate or cleft lip and cleft palate; children with congenital 
cytomegaly) in whom diagnostic practice revealed variable results of the wave V threshold. We analyzed the results of tests 
obtained during the first year of the child’s life divided into 4 diagnostic periods. 
  Results: The highest percentage of instability in the established threshold of wave V between individual diagnostic periods 
occurred in the group of children with cleft palate or cleft lip and cleft palate. In the group of children with Down syndrome, 
it was observed that the instability of the ABR test results decreased over time. In the group of children with other diseases or 
damage of the nervous system, the highest percentage of the lack of stable ABR wave V thresholds was observed between the 
1st and 2nd as well the 1st and 4th diagnostic periods. On the other hand, in the group of children with congenital CMV, there 
was a relatively low percentage of instability of results. 
  Conclusions: (1) Although the ABR test is a diagnostic standard, in particular groups of patients the study is burdened with 
high variability of measurement results in subsequent diagnostic periods. Such a group of patients are children with cleft 
palate or cleft lip and cleft palate; therefore, it must receive particular attention in treatment planning; (2) in selected groups 
at risk of hearing loss, due to the high percentage of children with hearing impairment (70%), the validity of performing 
newborn hearing screening tests was confirmed.
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ABBREVIATIONS
ABR – auditory brainstem response 
AI – impedance audiometry 
FDP – Low Pass Filter 
FGP – High Pass Filter 
PPPBSN – Program for Universal Hearing Screening in Newborns 
SNR – signal-to-noise ratio 
TEOAE – transient-evoked otoacoustic emission
INTRODUCTION
It has been argued that hearing problems in newborns are one 
of the most common irregularities in this period of life [1–3]. 
According to the data of the Great Orchestra of Christmas 
Charity, in the group of children aged 0 to 5, which is the most 
important period for speech development, as much as 90% of 
permanent damage is congenital [4]. Only half of children with 
congenital hearing impairment have risk factors for hearing im-
pairment. This means that without appropriate examinations, 
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Fig. 1.  General protocol for patients included in the Universal Hearing Screening Program [10].
period for the personnel performing the test. An advantage 
is that it does not require stringent local requirements 
to be met by neonatal departments performing the test 
– no silence cabin or protection against electromagnetic 
interference are required.
TEOAE is done on the second day of a child’s life. In the event of 
a positive result (abnormal hearing), the examination is repeated 
on the date of leaving the hospital. During the child’s stay in the 
neonatal unit, the staff collects information on risk factors affect-
ing the child’s hearing [1, 2].
Children with a positive screening result (hearing impairment) 
and children from so-called risk groups are referred to reference 
centers for further diagnosis and observation. Children at risk are 
referred to the above-mentioned centers even if the screening test 
result is negative (i.e. normal hearing).
The risk group of hearing disorders includes [3, 5, 7–9]:
• children with a family history of hearing impairment,
• children with a head and neck congenital anomaly,
• early babies < 33 hbd (week of pregnancy),
in these cases neither the doctors nor the parents have grounds 
to suspect the existence of a hearing problem in the child [5, 6].
In Poland, work on the standardization of screening procedures 
and their forms were carried out by the Diagnostic-Treatment-Re-
habilitation Center for the Deaf and Hearing Impaired “Cochle-
ar Center”, as well as the Institute of Physiology and Pathology of 
Hearing in Kajetany in 1995–1997.
Based on those studies, it was assumed that the best method of 
screening newborns’ hearing in the daily practice of neonatal de-
partments is transient-evoked otoacoustic emissions (TEOAE) 
with click stimuli, followed by ABR test [7]. The TEOAE technique 
was chosen for the following reasons:
• medical, as it is very effective in detecting hearing loss in 
children at such an early stage of life. Otoemission caused 
by click stimuli is already recorded in patients with hearing 
loss of less than 30–35 dB nHL. It is also argued that in 
subjects without hearing loss, click-evoked otoemission is 
present in almost 100% of cases;
• logistical and practical resulting from practicability of the 
test, the speed of performing the test and a short training 
I REFERENCE LEVEL – neonatal units









Second screening test (TEOAE – on the day of release from hospital)
III REFERENCE LEVEL – early intervention units
- adjustment of hearing aids and monitoring of apparatus-related benefits
- monitoring of child’s hearing
- psychological, logopedic, surdopedagogic, phoniatric care
- cooperation with local rehabilitation centers
II REFERENCE LEVEL – audiological 
and laryngological centers
-  audiological diagnostics
-  long-term observation of children with risk 
   factors for hearing impairment
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AUDITORY BRAINSTEM RESPONSE – ABR
A study involving the recording of biopotentials in the auditory 
nerve and brainstem in response to an acoustic stimulus. In clini-
cal practice, this test found application in assessment of the hear-
ing threshold, differential diagnosis (determination of the type of 
hearing loss), screening of hearing in newborns and infants, and 
monitoring of auditory nerve and brain stem function during neu-
rosurgical procedures [6, 11].
Due to the non-invasive nature of the test, ABR is performed in 
children from the first months of life. This test is also carried out 
in people with mental retardation, in whom it is not possible to 
conduct subjective and behavioral tests. This method is also used 
as a supplement to other previously performed objective tests 
(otoacoustic emission, impedance audiometry). 
The electrical activity of auditory areas within the brainstem 
is recorded by electrodes which are placed: 
• on the surface of the head, preferably at the top. Due to 
the presence of hair in this part of the head, the electrode 
is stuck to the patient’s forehead – it is an active, positive 
electrode,
• the second electrode is stuck to the mastoid or the earlobe 
of the side of the tested ear – it is a reference electrode, 
negative,
• the third electrode is stuck to the mastoid or the ear lobe of 
the opposite ear – it is a grounding electrode [7, 12].
The recorded response in the ABR test consists of several waves 
marked with Roman numerals. 
Areas of generation of individual waves: 
• wave I – distal portion of the auditory nerve, 
• wave II – proximal portion of the auditory nerve,
• children whose mother was infected with TORCH 
during pregnancy (toxoplasmosis, influenza virus, 
measles, Coxsackie viruses, B19 virus, rubella, 
cytomegaly, herpes virus),
• children who were administered ototoxic drugs after 
birth or whose mothers took ototoxic drugs during 
pregnancy,
• children diagnosed with jaundice requiring a transfusion 
at birth,
• children with a history of meningitis,
• children who were connected to the artificial ventilator 
> 5 days, 
• children who required intensive care > 7 days,
• children with impaired or absent vestibulo-ocular reflex 
70 dB,
• children with birth defects associated with hearing loss 
(genetic defects, neurological disorders, etc.),
• children with negative results of the hearing screening 
test in the hospital (no correct otoacoustic emission was 
registered).
 
Upon hearing that the “little” patient has trouble with hearing, 
we are mostly interested in the level of his hearing threshold. 
When the child is in the first year of life, we can only achieve 
results by means of ABR test. However, it turns out that sub-
sequent control tests, especially in children from the hearing 
loss risk groups selected in this study, produce variable, fluc-
tuating results. This is usually manifested by the instability of 
wave V threshold in subsequent diagnostic periods, which of-
ten leads to extending the implementation time of the appro-
priate proceedings. 
It seems, however, that knowing certain patterns regarding the 
wave V threshold occurring in individual groups at risk of hear-
ing loss, we are able to assume with a high degree of probabil-
ity the reason behind variable results in such a case, and thus 
attempt to implement effective measures.
Fig. 2.  Sample ABR test result: RIGHT EAR – response at the level of 30 and 20 dB nHL, ear with normal hearing; LEFT EAR – no response at 100 dB nHL, deaf ear (Racia-Alvar device 
with Centor C ver. 5.48PL).).
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hearing loss were analyzed. Additionally, we created 4 groups of 
little patients, who presented variable results of wave V thresh-
old in diagnostic practice. Inclusion of a patient in a given group 
was based on the test results provided by neonatal departments 
and a questionnaire completed by the ENT specialist during the 
patient’s first visit to the center.
The results of tests obtained during the first year of the child’s 
life were then analyzed; this related to the ABR test with click 
stimuli. Due to the high ratio of interference/artifact, the ABR 
test with stimulus in the form of tones of 500 Hz and 1000 Hz 
was not analyzed.
The first year of a child’s life was divided into 4 diagnostic periods:
• 1st diagnostic period 1–3 months of the child’s life,
• 2nd diagnostic period 4–6 months of child’s life, 
• 3rd diagnostic period 7–9 months of child’s life, 
• 4th diagnostic period 10–12 months of child’s life. 
  
Groups of children included in the study:
1. Children with Down syndrome – hearing loss is observed in 
over 60% of children in this group. Hearing loss is usually con-
ductive due to the presence of a narrow Eustachian tube and 
muscle hypotension, which causes more frequent accumulation 
of secretions, and more common infections of the upper and 
lower respiratory tract. Sensorineural or mixed hearing loss is 
less prevalent in this group [15];
2. Children with other diseases or damage to the nervous system 
– this group includes children diagnosed with damage to the 
nervous system after birth (hypoxic-ischemic encephalopathy, 
meningitis, hypertonia, hydrocephalus, cerebral palsy, epilepsy, 
other neurodegenerative diseases), as well as children whose 
final neurological diagnosis was not known at the time of au-
diological diagnosis, however, there was a serious suspicion 
of disease or damage to the nervous system (low Apgar score, 
low birth weight, intensive therapy, artificial ventilation. In the 
course of neurological diseases, the symptoms often indicate 
a possible damage to the auditory receptor and/or the audito-
ry pathway. However, in neurological conditions, hearing loss 
is a relatively rare disease symptom and is very uncommonly 
the leading manifestation of a neurological disease, and usually 
a component of a particular symptom complex. Children with 
neurological diseases practically never have hearing impair-
ments in case of damage at the cortical level, but those some-
times occur in damage to the brainstem. The largest group 
of hearing impairment in neurological diseases occurs in the 
course of vascular disorders in the central nervous system. 
Such disorders often take place in childbirth, when there is 
a hypoxic-ischemic encephalopathy, asphyxia. Intensive therapy 
and artificial ventilation are also necessary in premature and 
/or low birth weight children with a low Apgar score. Neonatal 
asphyxia can be associated with damage to the inner ear and 
the outer hair cells in the organ of Corti may disappear. There 
is a reasonable suspicion that these particular children may 
develop hearing problems [5, 16];
• wave III – cochlear nucleus,
• wave IV – superior olivary complex,
• wave V – lateral lemniscus. 
In audiological practice, the most frequently used identification is 
that of three registered characteristic waves occurring in this re-
cord, i.e. waves I, III, V, and the measurement of their latency and 
intervals between them [7, 12–14].
The error in the determination of hearing threshold established 
on the basis of wave V using a correctly performed ABR test 
usually does not exceed 10 dB. Therefore, this value is taken as the 
permissible measurement error.
The ABR test in children, and in particular in those whose results 
were analyzed in this study, i.e. before 1 year of age, is performed 
during sleep. The sleep of a little patient is an essential condition 
to obtain a meaningful input signal. In a situation where the child 
does not fall asleep due to disturbances generated by the little 
patient (crying, excessive mobility), the obtained results are unre-
liable and the test is repeated. In most centers, the sleep of a little 
patient is physiological, and thus the parents guardians are re-
quired to properly prepare their child. When establishing the date 
of ABR, parents/guardians are instructed about what happens at 
the assessment and how it is carried out. Furthermore, the child’s 
parents/guardians receive detailed written instructions. 
Some centers use pharmacological agents, e.g. chlorate hydrate in 
the form of rectal enemas, in order to avoid difficulties resulting 
from obtaining physiological sleep in young children. However, 
when it comes to using pharmacological agents during ABR, an 
earlier opinion of a pediatrician or family doctor regarding the 
child’s health condition is required, or in the case of full anesthe-
sia, the presence of an anesthesiologist, which is a major impedi-
ment for medical centers, clinics without hospital status or with-
out an anesthesiologist [14].
PURPOSE
The purpose of the paper is to analyze the stability of wave 
V threshold during the first year of life in children from selected 
risk groups for congenital hearing disorders.
MATERIAL AND METHODS
Inclusion criteria for patients
From a population of 2,114 patients tested in the years 2015–2016 
at the reference center participating in the Universal Neonatal 
Hearing Screening Program of the Specialist Center of Diagnosis 
and Rehabilitation for Children and Adolescents with Hearing 
Disabilities of the Polish Association of the Deaf in Krakow, the 
results of 250 children were subjected to retrospective analysis. 
Of these selected patients, 138 are girls and 112 are boys. The 
study group consisted of children from one to three months of age. 
The results of examinations of patients from the group at risk of 
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Criteria for evaluation of results
TEOAE
In the TEOAE study used in screening tests, as well as in tests 
at reference centers, the result is recorded in the form of an 
approved or rejected test, i.e. we accept as follows:
• negative result – test approved – the message “PASS” is 
displayed, which means that a correct otoacoustic signal has 
been registered – correct hearing;
• positive result – test rejected – the message “REFER” is 
displayed, indicating that a valid otoemission signal was not 
recorded – hearing loss suspected.
ABR (click stimuli)
Negative result: registering a wave V with correct latency for a stimu-
lus with an intensity of ≤ 30 dB nHL (the adopted standard: for 20 dB 
wave V latency – 7.9–9.0 ms; for 30 dB wave V latency – 7.3–8.1 ms). 
Positive result: wave V threshold greater than 35 dB nHL.
Technical parameters of the devices used in the research
1. Impedance audiometry was performed on Interacoustics 
AT 235 equipment:
• Pressure range + 225/-400 dPa,
• Measuring tone frequency 226 Hz or 1000 Hz,
• Upper limit of norm for compliance – 1.5 ml;
2. TEOAE testing was performed on Interacoustics OtoRead-
device with Database ver. 7.70.1. The TEOAE test protocol 
settings were as follows: 
• Number of test frequencies = 6,
• Averaging time = 64 seconds,
• Frequency range = 1.5 kHz to 4 kHz, 
• SNR (signal-to-noise ratio) for NORMAL (PASS) = 4 dB,
• Click-presentation level = 83 dB,
• Number of frequencies passed to pass the entire test to 
“NORMA” (PASS) = 4;
3. ABR – the test was performed on a Racia-Alvar device with 
software Centor C ver. 5.48PL. Test parameters:
• Type of stimuli – a click with a duration of 100 μs, 
• Short tone with Gaussian envelope,
3. Children with cleft palate or cleft lip and cleft palate – due 
to the distinctive anatomical features of the developmental 
defect in question, the suspicion of its presence is put for-
ward already in the delivery room or in the neonatal unit, 
therefore classification of the child in this group was based 
on the diagnosis obtained from the neonatal unit. Due to 
the abnormal function of the Eustachian tube, this group 
of patients is accompanied by a conductive component of 
hearing loss, which increases the hearing threshold. The 
cause of disturbances in the ventilation on Eustachian tube 
is failure of the muscles of the cleft palate. It is estimated that 
this group of patients is affected by conductive hearing loss 
in up to 50%, while sensorineural hearing loss is rare. The 
timing of surgery to close a cleft palate is of immense im-
portance. It is believed that prior closure of the cleft palate 
reduces the risk of hearing loss. Based on the literature, it 
can be concluded that patients who underwent surgery be-
fore the age of 1 were affected by hearing loss only in about 
10% of cases, while in the case of later surgery, there were 
almost 60% of cases with hearing loss [17, 18];
4. Children with congenital cytomegalovirus infection – the 
child was counted as part of this group on the basis of the di-
agnosis obtained from the neonatal unit and positive results 
of the antibody test (IgG, IgM) delivered during audiological 
diagnosis. The degree of unilateral or bilateral hearing loss 
resulting from the effects of cytomegalovirus on the organ 
of hearing may change during the child’s development. The 
virus enters numerous organs with blood and remains in the 
so-called latent phase of infection; it reactivates when im-
munity declines. Reduced sense of hearing may occur lat-
er than immediately after birth, and it may also progress. 
Therefore, even after preliminary audiological tests deter-
mining the child’s hearing as normal, periodic check-ups 
should not be discontinued until the age of 6 [19, 16, 20].
Inclusion criteria for patients from control group
The study group did not include children who, despite having 
hearing problems and classified as at risk of hearing loss, did 
not have the features of the above-mentioned 4 groups. The 
study group also did not include the test results of those chil-
dren whose parents/guardians changed the diagnostic cen-
ter during diagnosis. The results of examinations of children 
who died during the diagnostic period were not included in 
the study group.
Tab. I.  Summary of TEOAE screening results in the neonatal unit.
TYPE OF CONDITION NUMBER AND PERCENTAGE OF ANALYZED 
CHILDREN 
NUMBER AND PERCENTAGE OF CHILDREN 
WITH ABNORMAL (POSITIVE) RESULTS OF 
TEOAE SCREENING 
Children with Down syndrome 62 (24,8%) 58/62 (93,5%)
Children with other diseases or damage to the nervous system 66 (26,4%) 58/66 (87,5%)
Children with cleft palate or cleft lip and cleft palate 54 (21,6%) 35/54 (64,8%)
Children with congenital cytomegaly 68 (27,2%) 27/68 (39,4%)
Conclusion 250 (100%) 176/250 (70%)
WWW.OTOLARYNGOLOGYPL.COM6
original article
• 1st diagnostic period 1–3 months of child’s life,
• 2nd diagnostic period 4–6 months of child’s life, 
• 3rd diagnostic period 7–9 months of child’s life, 
• 4th diagnostic period 10–12 months of child’s life.  
During the diagnostic periods, the patients underwent an ABR exami-
nation. Based on the study, we determined and compared the percent-
age of results in which the difference of the established threshold of 
wave V compared to the study conducted in the previous diagnostic 
period was greater than 20 dB (Tab. II.). The results of ABR between 
the 1st and 4th study periods were also analyzed.  
BIOSTATISTICAL ANALYSIS
For the 1st and 2nd diagnostic period, for all selected groups it was 
observed that, with the exception of the group of children with con-
genital cytomegalovirus, this percentage oscillated between 30–34.8%. 
On the other hand, in the group of children with congenital CMV this 
percentage was 16.1%. When analyzing the 2nd and 3rd diagnostic 
periods, it was noted that the highest percentage of children with a 
hearing threshold change of more than 20 dB were those with a cleft 
palate or cleft palate and cleft lip – 47.8%. In the group of children 
with Down’s syndrome, this percentage was 40%. In the remaining 
analyzed groups, this share was 20% for children with other diseases 
or damage to the nervous system, and in the group of children with 
congenital CMV it was 9.7%. In the 3rd and 4th diagnostic periods, 
the highest percentage of unstable results was observed in the group 
of children with cleft palate or cleft palate and cleft lip – 60.9%. On 
the other hand, for the group of children with Down’s syndrome this 
percentage decreased to 30%. In the group of children with other 
diseases or damage to the nervous system, this percentage was 16%. 
For children with congenital cytomegaly, unstable results during this 
period were observed in 3.2% of patients. 
Verification of the mean annual changes showed that in the group 
of children with cleft palate or cleft palate and cleft lip, the high-
est frequency of changes was 50%. The lowest mean of the annu-
al variable was found in children with congenital CMV, amount-
ing to 10%. Also, between these groups it was observed that the 
results of mean changes, apart from significant algebraic differenc-
es, are statistically significant with the assumed significance level 
p = 0.05 (see Chart 2). In the remaining cases, no significant statisti-
cal differences were observed.
• Duration of short tone – 5 periods,
• Amplifier sensitivity – 50 μV/V,
• FGP – 160 Hz; FDP – 1.6 kHz,
• Masking – broadband noise (-30 dB),
• Plateau time – 0 ms,
• Stimulus polarity – alternating,
• Transducer type: DT 48 headphones from Beyer Dynamik,
• Analysis time – 12.5 ms,
• Triple repetition of registration of responses for a stimulus of 
the same intensity, 
• Hearing threshold criterion – the lowest stimulus intensity at 
which there was double response of wave V,
• Applied stimulus level – from 20 to 95 dB nHL in 10 dB step,
• Permissible error in establishing the hearing threshold 
determined on the basis of the 10 dB wave V,
• Electrode placement: (1) positive – high forehead, (2) 
negative – mastoid of examined ear, (3) grounding  
– mastoid of opposite ear. 
We used the Statistica software to calculate the basic data of descrip-
tive statistics – the arithmetic mean of the annual variability for the 
studied groups of patients was calculated along with the confidence 
interval for the determined means at the level of 95%. Student’s t-
distribution was used for the sample of n = 4 (4 measurement peri-
ods) during determination of the confidence interval. The obtained 
results were subjected to statistical analysis. The assumed level of 
significance was p < 0.05.
The study was approved by the Bioethics Committee of the Jagiel-
lonian University CM KBET/131/B2013.
RESULTS
The result of the TEOAE screening test performed in the neonatal 
unit was used as the initial test of the child’s hearing. The study group 
consisted of 250 “little” patients with diseases described in point 2, 
constituting the so-called risk group for congenital hearing loss. 
The further study included 176 patients enrolled based on TEOA 
screening. In order to observe the stability of wave V threshold de-
termined in ABR over the first year of the patient’s life, it was divided 
into 4 diagnostic periods (I–IV). The diagnostic periods were closely 
related to the patient’s life expectancy:
Tab. II. Percentage of the results of ABR in children from selected risk groups for congenital hearing impairment, in which the difference in the established threshold of wave V 
compared to the previous test and between periods 1st and 4th was greater than 20 dB.




Children with Down syndrome 30 40 30 20 30±8
Children with other diseases
 or damage to the nervous system 
32 20 16 28 24±7
Children with cleft palate or cleft lip and cleft palate 34,8 47,8 60,9 52,2 50±11
Children with congenital cytomegaly 16,1 9,7 3,2 9,7 10±5
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this observation indicate that in the 1st diagnostic period, children 
from this group repeatedly obtained results which to a large extent 
required checking and repetition of test. On the other hand, in the 
group of children with congenital cytomegalovirus, there was a rel-
atively low percentage of results instability [23]. Noteworthy is the 
comparison of results of the determined threshold of wave V from 
the 1st and 2nd periods where this percentage was the highest. The 
plausible cause for this could be the influence of other factors not di-
rectly related to the risk factor for hearing loss, such as other emerg-
ing diseases (infections), development of the nervous system, or the 
wave V threshold obtained in the first ABR study. 
During the study, in selected groups at risk of hearing loss we also 
observed that due to the high percentage of children with hearing 
impairment, as much as 70%, it is reasonable to perform newborn 
hearing screening. It was also concluded that although the ABR test 
is a diagnostic standard nowadays, in some groups of patients, espe-
cially in children with cleft palate or cleft palate and cleft lip, this test 
is burdened with high variability of measurement results in subse-
quent diagnostic periods. Therefore, it leads to an incorrect determi-
nation of the actual hearing threshold in the early diagnostic period 
and, consequently, to the extension of the correct final diagnosis [21]. 
Not only is the diagnostic time lengthening, but also the moment of 
introducing the final procedure.  Knowing this fact, doctors dealing 
with this group should analyze the planned treatment in a particular 
manner in connection with the knowledge about cleft-associated pro-
cedures in the affected children and other possible health burdens.
CONCLUSION
• The highest percentage of instability in the determined 
threshold of wave V between individual diagnostic periods 
occurred in the group of children with cleft palate or cleft palate 
and cleft lip;
• In the group of children with Down syndrome, it was observed 
that the instability of results of ABR tests decreased over time 
with subsequent tests in consecutive diagnostic periods;
• In the group of children with other diseases or damage to the 
nervous system, it is worth noting that the highest percentage 
of the lack of stable thresholds for wave V in the ABR study 
was observed between the 1st and 2nd as well as between the 
1st and 4th diagnostic periods. The results of this observation 
therefore indicate that in the 1st diagnostic period children 
from this group repeatedly had results which to a large extent 
required verification, and repetition of test;
• In the group of children with congenital cytomegalovirus there 
was a low percentage of instability of results; 
• Although the ABR test is a diagnostic standard, in particular 
groups of patients this study is burdened with high variability 
of measurement results in subsequent diagnostic periods. Such 
a group of patients are children with cleft palate or cleft lip and 
cleft palate; this must therefore receive particular attention in 
treatment planning;
• In selected groups at risk of hearing loss, due to the high 
percentage of children with hearing impairment (70%), the 
validity of performing newborn hearing screening tests was 
confirmed.
DISCUSSION
Thanks to the Program for Universal Hearing Screening in New-
borns (PPPBSN), early detection of hearing loss in Poland is now 
a standard, which not only ENT doctors, but also pediatricians or 
family doctors perceive as something common. This standard in-
cludes: screening of child on the 2nd day after birth, and in the event of 
a hearing problem (positive result), the test is repeated before the child 
is released home from the neonatal unit [2, 10].  Next, the children 
with a positive result, as well as those who belong to the so-called 
groups at risk of hearing loss, are referred to centers where further 
hearing diagnostics are performed. At this stage of the child’s hear-
ing monitoring, in addition to the repeated TEOAE test, other diag-
nostic methods are used, such as impedance audiometry (AI), and 
also to determine the hearing threshold potentials evoked from the 
brainstem (ABR – auditory brainstem responses) [21, 22].
As an objective method, ABR allows to effectively determine the scale 
of a hearing problem and directs the implementation of further pro-
cedures. Unfortunately, it has been observed that a major concern in 
audiological diagnosis, especially in the groups of children selected 
for this work, is the instability of obtained results [5, 23–25].
The analysis conducted in this paper allowed to determine, that the 
largest share of instability in the established wave V threshold be-
tween individual diagnostic periods occurred in the group of children 
with cleft palate or cleft palate and cleft lip. As already mentioned, in 
these children the emerging factors related to a developmental defect 
have a considerable impact on the level and quality of hearing in these 
children, and thus on the results of subsequent studies. That said, in 
the group of children with Down syndrome, we observe that the in-
stability of ABR test results decreases over time, which enables the 
attending physician to draw appropriate diagnostic conclusions and 
implement appropriate measures [15]. In the group of children with 
other diseases or damage to the nervous system, it is worth noting 
that the highest percentage of the lack of stable thresholds for wave 
V in the ABR study was observed between the 1st and 2nd as well as 
between the 1st and 4th diagnostic periods. Therefore, the results of 
Fig. 3.  Summary of the mean changes in the threshold of wave V between the research 
periods together with the confidence intervals with the assumed p = 0.05 for 
individual groups of studied children. 
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